Venus Concept Inc
VERO2.490USD
-0.030-1.19%
시장 운영 시간 （ET）시세는 15분 지연됩니다
1.77M시가총액
손실P/E TTM
자세한 내용은 Venus Concept Inc 회사
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
회사 정보
종목 코드 VERO
회사 이름Venus Concept Inc
상장일Oct 12, 2017
CEOMr. Rajiv De Silva
직원 수292
유형Ordinary Share
회계 연도 종료Oct 12
주소235 Yorkland Blvd Suite 900
도시TORONTO
증권 거래소NASDAQ Capital Market Consolidated
국가Canada
우편 번호M2J 4Y8
전화18778488430
웹사이트https://www.venusconcept.com/en-uk/
종목 코드 VERO
상장일Oct 12, 2017
CEOMr. Rajiv De Silva
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Mr. Scott Barry
Mr. Scott Barry
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Kirk Gunhus
Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
지역별USD
이름
수익
비율
United States
8.41M
61.62%
International
5.24M
38.38%
사업별
지역별
사업별USD
이름
수익
비율
Products—Systems
7.90M
57.93%
Subscription—Systems
2.65M
19.42%
Products—Other
2.42M
17.74%
Services
671.00K
4.92%
주식 보유 통계
마지막 업데이트: Tue, Jul 15
마지막 업데이트: Tue, Jul 15
주주
주주 유형
주주
주주
비율
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
주주
주주
비율
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Madryn Asset Management, LP
0.55%
UBS Financial Services, Inc.
0.49%
Other
85.94%
주주 유형
주주
비율
Venture Capital
7.54%
Investment Advisor
5.97%
Individual Investor
0.82%
Private Equity
0.55%
Hedge Fund
0.10%
Other
85.03%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
48
303.41K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
2023Q2
98
3.14M
119.96%
-1.42M
2023Q1
124
4.18M
259.89%
-397.96K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
+3.00
+0.00%
Jun 09, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
Madryn Asset Management, LP
10.19K
0.55%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
9.19K
0.49%
+4.02K
+77.78%
Mar 31, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Tower Research Capital LLC
1.78K
0.1%
+1.14K
+176.28%
Mar 31, 2025
Hollmig (Stanley Tyler)
1.76K
0.09%
--
--
Apr 28, 2025
Gunhus (Kirk)
1.64K
0.09%
+1.64K
--
Apr 28, 2025
Varghese (Hemanth Jacob)
1.52K
0.08%
+1.00
+0.07%
Apr 28, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
날짜
유형
비율
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
Feb 27, 2025
Merger
11<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
May 11, 2023
Merger
15<1
